NEW YORK, Dec. 21 /PRNewswire/ -- On December 18, Tim Hansen, Chief Executive Officer for Imaging Diagnostic Systems, Inc. updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview included the company's progress in seeking FDA Premarket Approval (PMA) for the Computed Tomography Laser Mammography (CTLM(R)) system to be used as an adjunct to mammography in the United States. Mr.Hansen also explained the significance of the company's recent press release announcing that the State Food and Drug Administration of the People's Republic of China (SFDA); the equivalent of the US Food and Drug Administration has approved that hospitals in the Beijing, China area may now charge patients for CT Laser Mammography (CTLM(R)) breast imaging procedures.
To hear the interview in its entirety, and to read an in-depth report on the company, please visit http://www.wallst.net/superstocks/superstocks_profile.asp?ticker=imds
About Imaging Diagnostic Systems:
Imaging Diagnostic Systems is a medical technology company involved primarily in the research and development of breast-imaging devices used for mammograms. Using laser-based technology, the company has created a more comfortable, radiation-free breast examination that does not require breast compression. The company has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The Computed Tomography Laser Mammography (CTLM(R)) system uses lasers to image the breast in a non-invasive procedure. Unlike x-ray mammography, CTLM images blood hemoglobin and the process of neoangiogenesis or new vessel formation which is often associated with breast cancer. The CTLM(R) system is a new continuous wave laser breast imaging system and utilizes state-of-the-art technology and patented algorithms to create 3-D images of the breast. The procedure is non-invasive, painless and does not expose the patient to radiation or require breast compression. The current CTLM will initially be used in conjunction with x-ray and ultrasound to assist in differentiating malignant from benign lesions and help reduce the great number of invasive biopsies performed which later prove to be negative. In the United States, Imaging Diagnostic Systems is seeking FDA Premarket Approval (PMA) for the Computed Tomography Laser Mammography (CTLM(R)) system to be used as an adjunct to mammography. The FDA has determined that the Company's clinical investigation is a non-significant risk (NSR) investigational device study because it does not meet the definition of a significant risk (SR) device under 812.3(m) of the investigational device exemptions (IDE) regulation (21 CFR 812). Currently, the CTLM system is limited by United States Federal Law to investigational use only in the United States. The Imaging Diagnostic Systems CTLM system has received other registrations including CE, CMDCAS Canadian License, China SFDA, UL, ISO 9001:2000, ISO 13485:2003 and FDA export certification.
About WallSt.net:
www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The website is a leading provider of financial news, media, tools and community-driven applications for investors. www.wallst.net offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies. We are expecting to receive two thousand dollars from Imaging Diagnostic Systems, Inc. for media and advertising services. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp .
(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comWallStreet Direct, Inc.CONTACT: Nick Iyer of Digital Wall Street, Inc., +1-800-4-WALL-ST
Web site: http://www.wallst.net/
